FDA 483 - Jilin Asymchem Laboratories Co., Ltd. - April 12, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Jilin Asymchem Laboratories Co., Ltd in Dunhua, Jilin, China, revealed significant deficiencies across multiple areas. The firm's laboratory equipment qualifications and software validations were found inadequate, particularly concerning data integrity and investigation of system errors. Additionally, cleaning validation protocols were insufficient, and laboratory investigations were not adequately performed, indicating a lack of robust quality control systems.
ID · 425fa42d-5cd1-4300-8764-ced015e8f9ec